Monika Vishnoi
Overview
Explore the profile of Monika Vishnoi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Yin Z, et al.
Lab Invest
. 2024 Oct;
104(12):102160.
PMID: 39426568
Precision oncology is driven by biomarkers. For glioblastoma multiforme (GBM), the most common malignant adult primary brain tumor, O-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation is an important prognostic and treatment...
2.
Vishnoi M, Dereli Z, Yin Z, Kong E, Kinali M, Thapa K, et al.
Res Sq
. 2024 Jul;
PMID: 38947019
Background: Interactions among tumor, immune, and vascular niches play major roles in driving glioblastoma (GBM) malignancy and treatment responses. The composition, heterogeneity, and localization of extracellular core matrix proteins (CMPs)...
3.
Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Delegard J, et al.
bioRxiv
. 2024 Apr;
PMID: 38586048
Precision oncology is driven by molecular biomarkers. For glioblastoma multiforme (GBM), the most common malignant adult primary brain tumor, O6-methylguanine-DNA methyltransferase ( ) gene DNA promoter methylation is an important...
4.
Vishnoi M, Dereli Z, Yin Z, Kong E, Kinali M, Thapa K, et al.
Res Sq
. 2023 Oct;
PMID: 37790408
Interactions among tumor, immune and vascular niches play major roles in driving glioblastoma (GBM) malignancy and treatment responses. The composition, heterogeneity, and localization of extracellular core matrix proteins (CMPs) that...
5.
Vishnoi M, Dereli Z, Yin Z, Kong E, Kinali M, Thapa K, et al.
bioRxiv
. 2023 Jun;
PMID: 37333072
Interactions among tumor, immune and vascular niches play major roles in driving glioblastoma (GBM) malignancy and treatment responses. The composition, heterogeneity, and localization of extracellular core matrix proteins (CMPs) that...
6.
Vishnoi M, Upadhyay R, Cho W
Front Mol Biosci
. 2022 Sep;
9:994506.
PMID: 36120554
No abstract available.
7.
Ren D, Cheng H, Wang X, Vishnoi M, Teh B, Rostomily R, et al.
Ther Adv Med Oncol
. 2020 Jul;
12:1758835920936151.
PMID: 32655700
Systemic therapies for primary breast cancer have made great progress over the past two decades. However, oncologists confront an insidious and particularly difficult problem: in those patients with metastatic breast...
8.
Vishnoi M, Liu N, Yin W, Boral D, Scamardo A, Hong D, et al.
Mol Oncol
. 2019 Jun;
13(9):1913-1926.
PMID: 31216110
Triple-negative breast cancer (TNBC) liver metastasis is associated with poor prognosis and low patient survival. It occurs when tumor cells disseminate from primary tumors, circulate in blood/lymph [circulating tumor cells...
9.
Sprouse M, Welte T, Boral D, Liu H, Yin W, Vishnoi M, et al.
Int J Mol Sci
. 2019 Apr;
20(8).
PMID: 31003475
Intratumoral infiltration of myeloid-derived suppressor cells (MDSCs) is known to promote neoplastic growth by inhibiting the tumoricidal activity of T cells. However, direct interactions between patient-derived MDSCs and circulating tumors...
10.
Vishnoi M, Marchetti D
Oncotarget
. 2019 Jan;
9(101):37464-37465.
PMID: 30680060
No abstract available.